Many PCPs Not Using Rx Drug Monitoring Programs Routinely

This article originally appeared here.
Share this content:
Many PCPs Not Using Rx Drug Monitoring Programs Routinely
Many PCPs Not Using Rx Drug Monitoring Programs Routinely

WEDNESDAY, March 4, 2015 (HealthDay News) -- Most primary care physicians are aware of state prescription drug monitoring programs, and more than half report using one, according to research published in the March issue of Health Affairs.

Lainie Rutkow, J.D., Ph.D., M.P.H., from Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues conducted a nationally representative mail survey involving 420 practicing primary care physicians. The authors examined attitudes toward and awareness and use of prescription drug monitoring programs in 2014.

The researchers found that 72 percent of physicians were aware of their state's prescription drug monitoring program, and more than half (53 percent) reported using one of the programs. Several barriers were identified to prevent greater program use, including the time-consuming nature of information retrieval and lack of an intuitive format for the data.

"These results suggest that the majority of U.S. primary care physicians are aware of and use prescription drug monitoring programs at least on occasion, although many did not access these programs routinely," the authors write. "To increase the use of the programs in clinical practice, states should consider implementing legal mandates, investing in prescriber education and outreach, and taking measures to enhance ease of access to and use of the programs."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths